Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with cyclosporine.

M Billing-Grima1, P Wolf

  • 1Institut de Pharmacologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.

Transplantation Proceedings
|March 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Importing biological materials.

Current protocols in protein science·2008
Same author

Functional units of the human foot.

Gait & posture·2008
Same author

Importing biological materials.

Current protocols in molecular biology·2008
Same author

Invasive in vivo measurement of rear-, mid- and forefoot motion during walking.

Gait & posture·2007
Same author

A MR imaging procedure to measure tarsal bone rotations.

Journal of biomechanical engineering·2007
Same journal

Acute Rejection Mediated by Preformed Anti-HLA-C Antibody in a Kidney Transplant Patient: A Case Report.

Transplantation proceedings·2026
Same journal

Liver Transplantation for Metastatic Neuroendocrine Tumors: A Single-Center Experience in a Brazilian Referral Center.

Transplantation proceedings·2026
Same journal

Analysis of the Cost of Maintaining Effective Donors and Nondonors of Organs and Tissues in Intensive Care Units.

Transplantation proceedings·2026
Same journal

Adolescence and Pediatric Heart Transplantation: Impact of Non-Adherence on Mortality: A Single-Center Experience.

Transplantation proceedings·2026
Same journal

Impact of Family-Based Care on the Outcome of Brain Death and Humanization in the Process of Multiple Organ Donation: Case Report.

Transplantation proceedings·2026
Same journal

Karnofsky Performance Status Is Associated with Patient and Graft Survival After Liver Retransplantation.

Transplantation proceedings·2026
See all related articles

Optimizing cyclosporine drug levels using C2 monitoring in liver transplant patients shows promise for reducing rejection. However, consistent target ranges require further definition based on assay methods and individual absorption patterns.

Area of Science:

  • Pharmacology
  • Transplantation Medicine
  • Clinical Chemistry

Background:

  • Cyclosporine drug monitoring is crucial for optimizing outcomes in organ transplantation.
  • The concentration at 2 hours after drug intake (C2) is a proposed parameter for adjusting cyclosporine regimens.
  • Accurate monitoring is essential to balance efficacy and toxicity in immunosuppressive therapy.

Purpose of the Study:

  • To evaluate preliminary C0 and C2 cyclosporine concentrations in liver transplant patients.
  • To assess the relationship between cyclosporine levels and acute rejection rates.
  • To investigate the impact of different assay techniques on cyclosporine concentration measurements.

Main Methods:

  • A prospective, single-center pharmacokinetic study involving 37 first-time liver transplant recipients.

Related Experiment Videos

  • Cyclosporine C0 and C2 levels were measured using immunoassay (EMIT) and high-performance liquid chromatography (HPLC).
  • Dose adjustments were guided by C0 levels, and clinical outcomes were assessed by acute rejection occurrence and severity.

    • Main Results:

    • Significant differences were observed in average C0 and C2 concentrations between EMIT and HPLC techniques.
    • Mean C2 (EMIT) values were generally within or near recommended ranges from day 3 onwards, correlating with a low rejection rate (8.8%).
    • Substantial inter-individual variability in cyclosporine levels was noted, with identification of low absorption profiles and a lower mean cyclosporine dose compared to previous studies.

    Conclusions:

    • Target ranges for cyclosporine monitoring may need adjustment based on the assay technique employed.
    • Defining an optimal cyclosporine regimen to achieve C2 goals and minimize rejection requires further investigation.
    • Population pharmacokinetic models are necessary to accurately describe and predict cyclosporine absorption variability in transplant patients.